ConductScience.org, home

Paper · 42162002

AI-genomics synergy for drug repurposing in breast cancer: an interpretability-driven framework.

Ahmad RM and 3 others. NPJ Genom Med, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. AI-genomics synergy for drug repurposing in breast cancer: an interpretability-driven framework. Papers, record 42162002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42162002

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
AI-genomics synergy for drug repurposing in breast cancer: an interpretability-driven framework.
PubMed
Journal
NPJ Genom Med
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-09-16
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ahmad RMRahaf M
2Aburuz SSalahdein
3Ali BRBassam R
4AlDhaheri NNoura

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Strategic Research Program (#12R111)Zayed Bin Sultan Center for Health Sciences, United Arab Emirates UniversityPubMed
PhD fellowshipCollege of Graduate Studies, United Arab Emirates UniversityPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References66

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,228,466A computational approach to drug repurposing using graph neural networks.Comput Biol Med2022https://conductscience.org/library/papers/36228466PubMed
233,015,372The future of digital health with federated learning.NPJ Digit Med2020https://conductscience.org/library/papers/33015372PubMed
331,691,815The reactome pathway knowledgebase.Nucleic Acids Res2020https://conductscience.org/library/papers/31691815PubMed
437,600,670HER2-Low Breast Cancer: Current Landscape and Future Prospects.Breast Cancer (Dove Med Press)2023https://conductscience.org/library/papers/37600670PubMed
538,612,893Metformin: A Dual-Role Player in Cancer Treatment and Prevention.Int J Mol Sci2024https://conductscience.org/library/papers/38612893PubMed
624,735,618TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.J Cheminform2014https://conductscience.org/library/papers/24735618PubMed
730,508,424Ensuring Fairness in Machine Learning to Advance Health Equity.Ann Intern Med2018https://conductscience.org/library/papers/30508424PubMed
837,965,341Application of single-cell sequencing to the research of tumor microenvironment.Front Immunol2023https://conductscience.org/library/papers/37965341PubMed
934,552,244Biologically informed deep neural network for prostate cancer discovery.Nature2021https://conductscience.org/library/papers/34552244PubMed
1039,215,014AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer.Nat Commun2024https://conductscience.org/library/papers/39215014PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42162002

GET https://conductscience.org/api/papers/v1/42162002/references?page=2